Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

JAMA Study Reports Long-Term Advanced Imaging Growth In HMO Patients

This article was originally published in The Gray Sheet

Executive Summary

Findings parallel fee-for-service data, but could be helpful in teasing out impact of financial incentives, researchers say. Meanwhile, radiologists and equipment makers point out the data shows that some of the growth trends halted in recent years.

You may also be interested in...



Slowdown In Use Of Advanced Imaging Driven By Multiple Factors, Study Finds

A recent Health Affairs study finds that a variety of policies have helped curb the ordering of imaging studies that have unproven medical value.

MedPAC Forwards More Ideas To Reduce Advanced Imaging Spending

The Medicare Payment Advisory Commission outlined four draft recommendations last week intended to either reduce payments for or control use of advanced imaging tools. Among the ideas: a prior authorization program specifically targeting physicians who order the most imaging scans.

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031313

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel